These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19456254)

  • 1. Biodegradable intrascleral implant of triamcinolone acetonide in experimental uveitis.
    Shin JP; Park YC; Oh JH; Lee JW; Kim YM; Lim JO; Kim SY
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):201-8. PubMed ID: 19456254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.
    Sakurai E; Nozaki M; Okabe K; Kunou N; Kimura H; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4845-52. PubMed ID: 14578407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
    Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of low-release-rate fluocinolone acetonide intravitreal implants to treat experimental uveitis.
    Mruthyunjaya P; Khalatbari D; Yang P; Stinnett S; Tano R; Ashton P; Guo H; Nazzaro M; Jaffe GJ
    Arch Ophthalmol; 2006 Jul; 124(7):1012-8. PubMed ID: 16832025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.
    Jaffe GJ; Yang CS; Wang XC; Cousins SW; Gallemore RP; Ashton P
    Ophthalmology; 1998 Jan; 105(1):46-56. PubMed ID: 9442778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of biodegradable controlled release scleral systems of triamcinolone acetonide.
    Blatsios G; Tzimas AS; Mattheolabakis G; Panagi Z; Avgoustakis K; Gartaganis SP
    Curr Eye Res; 2010 Oct; 35(10):916-24. PubMed ID: 20858113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis.
    Cheng CK; Berger AS; Pearson PA; Ashton P; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):442-53. PubMed ID: 7843913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved anti-inflammatory effects in rabbit eye model using biodegradable poly beta-amino ester nanoparticles of triamcinolone acetonide.
    Sabzevari A; Adibkia K; Hashemi H; De Geest BG; Mohsenzadeh N; Atyabi F; Ghahremani MH; Khoshayand MR; Dinarvand R
    Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5520-6. PubMed ID: 23833065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular concentration of triamcinolone acetonide after intravitreal injection in the rabbit eye.
    Kamppeter BA; Cej A; Jonas JB
    Ophthalmology; 2008 Aug; 115(8):1372-5. PubMed ID: 18355920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous pharmacokinetics and retinal safety of intravitreal preserved versus non-preserved triamcinolone acetonide in rabbit eyes.
    Oliveira RC; Messias A; Siqueira RC; Bonini-Filho MA; Haddad A; Damico FM; Maia-Filho A; Crispim PT; Saliba JB; Ribeiro JA; Scott IU; Cunha AS; Jorge R
    Curr Eye Res; 2012 Jan; 37(1):55-61. PubMed ID: 22029458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of intravitreal and orbital floor triamcinolone acetonide injection on intraocular inflammation in patients with active non-infectious uveitis].
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Klin Monbl Augenheilkd; 2009 Feb; 226(2):110-4. PubMed ID: 19206044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.
    Inoue M; Takeda K; Morita K; Yamada M; Tanigawara Y; Oguchi Y
    Am J Ophthalmol; 2004 Dec; 138(6):1046-8. PubMed ID: 15629301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal implantation of the biodegradable cyclosporin A drug delivery system for experimental chronic uveitis.
    Dong X; Shi W; Yuan G; Xie L; Wang S; Lin P
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr; 244(4):492-7. PubMed ID: 16163496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable scleral implants as new triamcinolone acetonide delivery systems.
    Felt-Baeyens O; Eperon S; Mora P; Limal D; Sagodira S; Breton P; Simonazzi B; Bossy-Nobs L; Guex-Crosier Y; Gurny R
    Int J Pharm; 2006 Sep; 322(1-2):6-12. PubMed ID: 16824708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal pharmacokinetics after posterior subtenon triamcinolone acetonide injection in vitrectomized rabbit eyes.
    Park HJ; Lee JE; Kim SI; Pak KY; Oum BS; Lee JS; Jung JH; Lee JE
    Retina; 2014 Apr; 34(4):801-6. PubMed ID: 24077088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.
    Okabe J; Kimura H; Kunou N; Okabe K; Kato A; Ogura Y
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):740-4. PubMed ID: 12556407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of intraoperative intravitreal injection of triamcinolone acetonide injection after phacoemulsification in cases of uveitic cataract.
    Dada T; Dhawan M; Garg S; Nair S; Mandal S
    J Cataract Refract Surg; 2007 Sep; 33(9):1613-8. PubMed ID: 17720079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles.
    Gilger BC; Abarca EM; Salmon JH; Patel S
    Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2483-92. PubMed ID: 23532526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between intravitreal and orbital floor triamcinolone acetonide after phacoemulsification in patients with endogenous uveitis.
    Roesel M; Tappeiner C; Heinz C; Koch JM; Heiligenhaus A
    Am J Ophthalmol; 2009 Mar; 147(3):406-12. PubMed ID: 19054496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.